GreenLight Biosciences and Samsung Biologics have signed a collaboration agreement for manufacturing messenger ribonucleic acid (mRNA) Covid-19 vaccines. Under the terms of the agreement, Samsung Biologics will be responsible for the production of GreenLight’s mRNA […]
An independent data monitoring committee (DMC) has recommended First Wave BioPharma to continue enrolment for the second part of its ongoing RESERVOIR Phase II trial of FW-COV to treat gastrointestinal (GI) infections related to Covid-19. […]
Gritstone bio has reported that the mutations seen within the Omicron (B.1.1.529) variant of the SARS-CoV-2 virus does not affect the viruses’ T cell epitopes (TCEs) delivered along with its self-amplifying messenger ribonucleic acid (mRNA) […]
Quell Therapeutics has raised $156m funding through an oversubscribed Series B funding round to advance its multi-modular engineered T regulatory (Treg) cell therapy pipeline and platform. Quell Therapeutics has raised $156m funding through an oversubscribed […]